As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s...
Lisa Ricciardi, Cognition Therapeutics president and CEO
By Alex Philippidis
With Eisai and Biogen winning full FDA approval in July for Leqembi® (lecanumab-irmb), and Eli Lilly expecting an agency decision on donanemab by year’s end, a...
Global surge of highly pathogenic avian influenza H5N1
In a recent study published in the journal Nature, researchers uncovered the ecological and virological dynamics behind the intensified global activity of highly pathogenic avian influenza (HPAI) H5N1 since 2021. Study: The episodic resurgence of...
Alliance presents detailed results from phase III CABINET pivotal Trial evaluating cabozantinib in advanced...
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo in two cohorts of...
ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC). Results...
Bioengineering team wins health care innovation competition
Four senior bioengineering students at The University of Texas at Arlington have won the Biomedical Engineering Society (BMES) Coulter College for Healthcare Innovation competition for their work on an early detection device for atrial...
Microbial Cross-Feeding Scores Uncover Interactions That Influence Gut Health
An international research team led by scientists at the Hudson Institute of Medical Research has found a way to determine which species of gut microbiota are important in certain diseases, and how they interact...
In Silico Antibody Design: Navigating Latest Trends and Envisioning Future Technologies
REGISTER NOW
Broadcast Date: December 13, 2023 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibodies, as powerful therapeutic agents, have demonstrated immense potential in treating a range of diseases, from cancer to infectious...
Reproducible Peptide Mapping for Biotherapeutics Development
REGISTER NOW
Broadcast Date: November 27, 2023 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Peptide mapping is a critical quality test to confirm the primary structure of proteins used in biotherapeutics such as...
New method uses magnets to align muscle cells
Stimulating muscle fibers with magnets causes them to grow in the same direction, aligning muscle cells within tissue, Massachusetts Institute of Technology (MIT) and Boston University investigators report October 20 in the journal Device....
New method to study gut microbiome opens door to new medical opportunities
The more diverse species in your gut, the better it is for your health. Now an international team led by the Hudson Institute of Medical Research has found a way to determine which species...
